Switzer TV

This week's Switzer Report sees us celebrating the new year. The new financial year, that is. We get our expert stock pickers - Jun Bei Liu of TenCap and Adam Dawes of Shaw and Partners - to give us three stocks each that they're eyeing in the new year. We're also joined by Propertyology's Simon Pressley about what property prices will dowhen we turn over the financial calendar.

Plus, Paul Rickard joins us to talk about Xero's recent $3.9 billon acquisition.

 

 

Subscribe to Switzer

  • Switzer Report - https://switzerreport.com.au/subscribe
  • Switzer Daily - https://switzer.com.au/subscribe
Switzer Investing TV | 30 June 2025: A new (financial) year is here - what would our experts buy on the share market?

We got our stock pickers to show us three stocks each that they're eyeing in the new year. Here are their new financial year stocks. Plus: what's going to happen with house pricing in the near-term?

More videos

Michael Wayne on these stocks & more; TYR, APX, DDR + What's going on in the housing market?

Peter Switzer is joined by Michael Wayne of Medallion Financial, ST Wong of Prime Value, and CEO of Rate Money, Ryan Gair.

Series:
Are we heading for a recession? + Expert analysis on these 7 stocks!

Peter Switzer is joined by Michael Gable of Fairmont Equities, and Marcus Bogdan of Blackmore Capital.

Series:
A promising male contraception pill with zero effects on hormones?! | The Check Up

Currently, the only form of male contraception is a condom and a vasectomy. However, through certain studies and research conducted with mice, we may soon see a contraception pill for males with no hormonal effects.

Series:
Mad about Money

3 reasons why Dr Phil better be careful about raising interest rates & could stocks slide tomorrow?

Series:
5 quality stocks; GMG, ANZ, XRO, JBH & S32 + Should we fear the fed interest rate decision?

Peter Switzer is joined by Jun Bei Liu of Tribeca Investment Partners, Anthony Doyle from Firetrail Investments and Paul Rickard is joined by Angus Moore from Proptrack.

Series:
What is immunotherapy and how does it fight cancer? | The Check Up

Dr Ross explains whether immunotherapy could be the new approach that could lead to an effective treatment for various types of cancer.

Series:
4 mid-cap stocks for your portfolio + How do you renovate or build and stay within your budget?

Paul Rickard is joined by Rudi Filapek-Vandyck of FNArena, Raymond Chan of Morgans, and Anna Porter from Suburbanite.

Series:
Mad about Money

US inflation disappoints & Wall Street tanks + Star Entertainment: 'Unfit to hold casino license'.

Series:
Why are copper, nickel and lithium stocks on the rise? + 3 growth companies; DGL, PPE & SMP

Paul Rickard is joined by Michael Wayne of Medallion Financial, Adam Dawes of Shaw and Partners, and Ron Shamgar of Tamim Asset Management.

Series:
Can a high dose of vitamin E really cause death? | The Check Up

Dr Ross has a look at whether a high dose of vitamin E can actually lead to death, as some studies show.

Series:
Are ALX & WES a buy? + Is the property market stronger than what doomsayers would have us believe?

Paul Rickard is joined by Marcus Bogdan of Blackmore Capital, Eleanor Creagh of PropTrack, and Michael Knox of Morgans.

Series:
Mad about Money

Paul Rickard shares his thoughts on the major current affairs impacting financial markets and the economy.

Series:
1 9 10 11 12 13 50

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram